NR every week? Come onAgreed on that “NR every week” comment. Unless we are bought out or sued or something along those rare lines, there is only one NR we can be sure of and it will come in June from the EPO (acceptance or refusal).
Mgmt is optimistic about the upcoming response and in the Nov 2018 MD&A it was estimated we would receive acceptance this summer. Such news would likely be followed by a deal of some sort and announcement of pursuing patents in new strategic areas (i.e jumping from patent pending to applying for examination in CA).
Nonetheless, wouldn’t be surprised to see this thing trickle back to $0.10. Waiting until June could be too long for some investors, so this is likely but is not disheartening for longs.